BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2915282)

  • 1. Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen.
    Trivedi P; Hindmarsh P; Risteli J; Risteli L; Mowat AP; Brook CG
    J Pediatr; 1989 Feb; 114(2):225-30. PubMed ID: 2915282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy.
    Tapanainen P; Risteli L; Knip M; Käär ML; Risteli J
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1244-9. PubMed ID: 3192681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders.
    Trivedi P; Risteli J; Risteli L; Hindmarsh PC; Brook CG; Mowat AP
    Pediatr Res; 1991 Sep; 30(3):276-80. PubMed ID: 1945568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
    Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
    Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone alkaline phosphatase and collagen markers as early predictors of height velocity response to growth-promoting treatments in short normal children.
    Crofton PM; Stirling HF; Schönau E; Kelnar CJ
    Clin Endocrinol (Oxf); 1996 Apr; 44(4):385-94. PubMed ID: 8706304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term monitoring of treatment with recombinant human growth hormone by serial determinations of type III procollagen-related antigens in serum.
    Danne T; Grüters A; Schnabel K; Burger W; L'Allemand D; Enders I; Helge H; Weber B
    Pediatr Res; 1988 Feb; 23(2):167-71. PubMed ID: 3353159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of type I and III procollagen propeptides in healthy children and girls with central precocious puberty during treatment with gonadotropin-releasing hormone analog and cyproterone acetate.
    Hertel NT; Stoltenberg M; Juul A; Main KM; Müller J; Nielsen CT; Lorenzen I; Skakkebaek NE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):924-7. PubMed ID: 8473407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of procollagen type III propeptide-related antigens in serum to somatic growth in healthy children and patients with growth disorders.
    Danne T; Grüters A; Schuppan D; Quantas N; Enders I; Weber B
    J Pediatr; 1989 Feb; 114(2):257-60. PubMed ID: 2915284
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.
    Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; Di Nero G
    J Pediatr; 1993 Jan; 122(1):37-45. PubMed ID: 8419613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline crosslinked telopeptide of type I collagen in normal children and children with growth hormone (GH) deficiency during GH therapy.
    Kubo T; Tanaka H; Inoue M; Kanzaki S; Seino Y
    Bone; 1995 Oct; 17(4):397-401. PubMed ID: 8573414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen metabolites in the prediction of response to GH therapy in short children.
    Tapanainen P; Knip M; Risteli L; Kemppainen L; Käär ML; Risteli J
    Eur J Endocrinol; 1997 Dec; 137(6):621-5. PubMed ID: 9437226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen in children with growth retardation.
    Cinaz P; Hasanoglu E; Gökçora N; Dogukan S; Demir A
    Mater Med Pol; 1994; 26(2):55-8. PubMed ID: 7745984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum N-Terminal Type III Procollagen Propeptide: An Indicator of Growth Hormone Excess and Response to Treatment in Feline Hypersomatotropism.
    Keyte SV; Kenny PJ; Forcada Y; Church DB; Niessen SJ
    J Vet Intern Med; 2016 Jul; 30(4):973-82. PubMed ID: 27425382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical, physiologic, and clinical validation of a radioimmunoassay for measurement of procollagen type III amino terminal propeptide in serum and bronchoalveolar lavage fluid obtained from dogs.
    Schuller S; Valentin S; Remy B; Jespers P; Foulon S; Van Israël N; Clercx C; McEntee K
    Am J Vet Res; 2006 May; 67(5):749-55. PubMed ID: 16649905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoterminal propeptide of type III procollagen in cord blood and amniotic fluid of high-risk pregnancies: a biochemical approach to the dynamic assessment of deviant fetal growth.
    Vanhaesebrouck P; Kint J; Van Kets H; Govaert P; Smets K; Defoort P; Leroy J
    Pediatr Res; 1994 Jul; 36(1 Pt 1):71-6. PubMed ID: 7936841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoterminal propeptide of type III procollagen in cord blood and amniotic fluid of appropriate-for-gestational-age infants: a predictor of age-related fetal growth rate.
    Vanhaesebrouck P; Kint J; Dhont M; De Praeter C; Leroy J
    Pediatr Res; 1994 Jul; 36(1 Pt 1):64-70. PubMed ID: 7936839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen formation and degradation increase during growth hormone therapy in children.
    Vihervuori E; Turpeinen M; Siimes MA; Koistinen H; Sorva R
    Bone; 1997 Feb; 20(2):133-8. PubMed ID: 9028537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of collagen synthesis and linear growth by growth hormone in glucocorticoid-treated children.
    Allen DB; Goldberg BD
    Pediatrics; 1992 Mar; 89(3):416-21. PubMed ID: 1741214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in serum type I and III procollagen levels in children with chronic renal failure.
    Cinaz P; Buyan N; Gökçora N; Elbeg S; Hasanoğlu E
    Nephron; 1996; 72(2):189-91. PubMed ID: 8684525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoterminal propeptide of type III procollagen in the follow-up of patients with abdominal aortic aneurysms.
    Satta J; Haukipuro K; Kairaluoma MI; Juvonen T
    J Vasc Surg; 1997 May; 25(5):909-15. PubMed ID: 9152320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.